Indazolyl triazol derivatives
US9073892B2 · kind B2 · utility
6Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2011 |
| Grant date | Jul 7, 2015 |
| Priority date | — |
| Expiry date | Dec 16, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I)are used for the treatment of inflammation and autoimmune disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.